Trial Profile
Phase I/II clinical trial:Immunotherapy of hormone-refractory prostate cancer patients with dendritic cell-based vaccine
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 12 Sep 2013
Price :
$35
*
At a glance
- Drugs Stapuldencel-T (Primary)
- Indications Prostate cancer
- Focus Adverse reactions
- 22 Jun 2011 New trial record